112 related articles for article (PubMed ID: 17361223)
1. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts.
Durual S; Rideau A; Ruault-Jungblut S; Cossali D; Beris P; Piguet V; Matthes T
Leukemia; 2007 May; 21(5):1050-9. PubMed ID: 17361223
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of hypoxia-inducible factor-1 alpha protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid.
Zhang J; Song LP; Huang Y; Zhao Q; Zhao KW; Chen GQ
Haematologica; 2008 Oct; 93(10):1480-7. PubMed ID: 18728026
[TBL] [Abstract][Full Text] [Related]
4. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
5. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
[TBL] [Abstract][Full Text] [Related]
6. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.
Bruserud Ø; Hovland R; Wergeland L; Huang TS; Gjertsen BT
Haematologica; 2003 Apr; 88(4):416-28. PubMed ID: 12681969
[TBL] [Abstract][Full Text] [Related]
7. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.
Iida H; Towatari M; Iida M; Tanimoto M; Kodera Y; Ford AM; Saito H
Int J Hematol; 2000 Feb; 71(2):153-8. PubMed ID: 10745625
[TBL] [Abstract][Full Text] [Related]
8. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
9. Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation.
Haimovici A; Brigger D; Torbett BE; Fey MF; Tschan MP
Leuk Res; 2014 Sep; 38(9):1041-7. PubMed ID: 25043887
[TBL] [Abstract][Full Text] [Related]
10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
11. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
Fliegauf M; Stock M; Berg T; Lübbert M
Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
[TBL] [Abstract][Full Text] [Related]
12. PU.1 and CEBPA expression in acute myeloid leukemia.
D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
Mueller BU; Pabst T; Osato M; Asou N; Johansen LM; Minden MD; Behre G; Hiddemann W; Ito Y; Tenen DG
Blood; 2002 Aug; 100(3):998-1007. PubMed ID: 12130514
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
16. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
17. Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses.
Koya RC; Kasahara N; Pullarkat V; Levine AM; Stripecke R
Leukemia; 2002 Sep; 16(9):1645-54. PubMed ID: 12200676
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
Lin LI; Chen CY; Lin DT; Tsay W; Tang JL; Yeh YC; Shen HL; Su FH; Yao M; Huang SY; Tien HF
Clin Cancer Res; 2005 Feb; 11(4):1372-9. PubMed ID: 15746035
[TBL] [Abstract][Full Text] [Related]
19. Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP.
Manabe N; Yamamoto H; Yamada T; Kihara-Negishi F; Hashimoto Y; Mochizuki M; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1345-50. PubMed ID: 12739003
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor in acute myeloid leukemia.
Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]